Semaglutide shortage in the United States has become an issue of great concern to pharmaceutical manufacturers. Semaglutide is commonly prescribed to manage type 2 diabetes and aid weight loss. Semaglutide availability has decreased significantly, which has raised concerns among both patients and healthcare providers alike.

Semaglutide has been proven to be a safe option for weight loss, despite some possible side effects. Compared to other weight loss medications on the market, semaglutide has fewer side effects.